Coherus Biosciences | CHRS - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Akebia Therapeutics USD 13.02M 22K 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amarin USD 164.07M 19.51M 2026-06
Amgen USD 6.22B 34M 2026-06
Baxter International USD 2.26B 57M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Coherus Biosciences USD 5.67M 842K 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Fujifilm JPY 600.8B 678M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
Merck USD 6.21B 272M 2026-06
Myriad Genetics USD 30.6M 2.7M 2026-06
Pacira USD 134.57M 15.8M 2026-06
Perrigo USD 1.06B 56.9M 2026-06
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06
Zoetis USD 2.57B 24M 2026-06